Vaccines
-
Caught my eye — 2/28/25
Read more: Caught my eye — 2/28/25Tariffic. This week Eli Lilly announced they were investing at least $27 billion in US manufacturing, which is pretty cool. Was it to buy favor with the new Administration? It certainly does not hurt. I get the allure of manufacturing in the United States. If a country wanted to hurt us, they could stop sending…
-
Caught my eye — 2/21/25
Read more: Caught my eye — 2/21/25Discontinued: A flu vaccination campaign got pulled by the Department of Health and Human Services (HHS). It is off the air and the website was taken offline and now directs users to older information and not the new campaign (“Wild to Mild”.) 1 in 5. Did you know that 1 in 5 people in the…
-
Caught my eye — 2/23/24
Read more: Caught my eye — 2/23/24Gross to Net, a Saga. As soon as I saw Adam Fein’s Drug Channels article on Gross to Net in Part D redesign, I knew it would throw off my day. It was just catchy enough to cause a buzz and get the attention of Heads of Market Access at pharmaceutical companies and start the…
-
Caught my eye — 10/13/23
Read more: Caught my eye — 10/13/23Medicare Math. Medicare Part B premiums will go up about 6% next year, Social Security cost of living adjustment will be 3.2%. Really Stupid Vaccine Policies. Sometimes a story hits just right like this Washington Post opinion piece on RSV vaccines for adults and how the access is harmed by coverage policies. This year two…
Latest news
- Catch as Catch Can
- Make IRA Better
- Spring break broke me
- Caught my eye — 4/11/25
- Caught my eye — 4/4/25
Categories
- 340B (34)
- Affordable Care Act (4)
- Alzheimer's (5)
- Biosimilars (21)
- Caught my eye (63)
- Cell and Gene (1)
- Chevron Deference (2)
- CMMI (11)
- Copay Accumulators (6)
- COVID (2)
- Drug Prices (32)
- Drug shortages (9)
- DTC (2)
- Employers (7)
- Generics (5)
- Health Equity (3)
- Healthcare Costs (28)
- ICER (10)
- Importation (2)
- Inflation Reduction Act (48)
- Insulin (4)
- IP (3)
- Long term care (1)
- Medicaid (6)
- Medicare Advantage (16)
- Medicare Negotiation (50)
- Medicare Part D (46)
- Medicare Transaction Facilitator (3)
- Medicare Transaction Facilitator (8)
- Obesity (21)
- On the Horizon (1)
- Orphan Drugs (3)
- Pharmacy Benefit Managers (29)
- Reference Pricing (6)
- State-based Reform (15)
- Supply Chain (2)
- Uncategorized (6)
- Utilization Management (1)
- Vaccines (4)
- Value (13)